111 Return on Tangible Equity 2018-2024 | YI

Current and historical return on tangible equity values for 111 (YI) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
111 Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2024-12-31 $-0.01B $-0.09B 10.26%
2024-09-30 $-0.04B $-0.09B 41.74%
2024-06-30 $-0.05B $-0.09B 57.85%
2024-03-31 $-0.05B $-0.08B 70.43%
2023-12-31 $-0.06B $-0.08B 80.58%
2023-09-30 $-0.04B $-0.07B 64.57%
2023-06-30 $-0.04B $-0.06B 71.79%
2023-03-31 $-0.05B $-0.06B 88.07%
2022-12-31 $-0.06B $-0.06B 123.08%
2022-09-30 $-0.06B $-0.05B 160.00%
2022-06-30 $-0.09B $-0.05B 301.69%
2022-03-31 $-0.10B $-0.04B 851.06%
2021-12-31 $-0.11B $-0.03B -1200.00%
2021-09-30 $-0.11B $-0.01B -360.33%
2021-06-30 $-0.09B $0.03B -172.86%
2021-03-31 $-0.07B $0.04B -115.18%
2020-12-31 $-0.07B $0.06B -91.50%
2020-09-30 $-0.07B $0.07B -77.75%
2020-06-30 $-0.07B $0.08B -67.15%
2020-03-31 $-0.07B $0.09B -59.50%
2019-12-31 $-0.07B $0.11B -51.99%
2019-09-30 $-0.07B $0.13B -42.63%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.068B $1.973B
111, Inc. operates as a digital and mobile healthcare platform. The Company offers pharmacy distribution, medical consultancy, e-prescription and other services. 111, Inc. is headquartered in Shanghai, China.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $39.499B 54.56
Hims & Hers Health (HIMS) United States $14.471B 150.35
Tempus AI (TEM) United States $11.278B 0.00
Inspire Medical Systems (INSP) United States $4.503B 70.36
IRhythm Technologies (IRTC) United States $4.501B 0.00
Privia Health (PRVA) United States $3.050B 208.50
Enovis (ENOV) United States $2.060B 11.48
Clover Health Investments (CLOV) United States $1.807B 0.00
Schrodinger (SDGR) United States $1.722B 0.00
Phreesia (PHR) United States $1.510B 0.00
Omnicell (OMCL) United States $1.310B 23.11
Azenta (AZTA) United States $1.258B 58.45
10x Genomics (TXG) United States $1.156B 0.00
Fulgent Genetics (FLGT) United States $0.620B 0.00
Butterfly Network (BFLY) United States $0.581B 0.00
Talkspace (TALK) United States $0.499B 149.00
Veradigm (MDRX) United States $0.455B 0.00
Claritev (CTEV) United States $0.450B 0.00
Standard BioTools (LAB) United States $0.410B 0.00
TruBridge (TBRG) United States $0.376B 834.67
Health Catalyst (HCAT) United States $0.283B 0.00
Nyxoah SA (NYXH) Belgium $0.214B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.197B 0.00
EUDA Health Holdings (EUDA) Singapore $0.142B 0.00
Pulmonx (LUNG) United States $0.138B 0.00
American Well (AMWL) United States $0.116B 0.00
MDxHealth SA (MDXH) Belgium $0.099B 0.00
CareCloud (CCLD) United States $0.089B 3.39
Outset Medical (OM) United States $0.070B 0.00
Retrieve Medical Holdings (RMHI) United States $0.059B 0.00
P3 Health Partners (PIII) United States $0.057B 0.00
HeartBeam (BEAT) United States $0.052B 0.00
Zepp Health (ZEPP) Netherlands $0.040B 0.00
Zhongchao (ZCMD) China $0.032B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.023B 0.00
Bullfrog AI Holdings (BFRG) United States $0.016B 0.00
MSP Recovery (MSPR) United States $0.013B 0.00
Precipio (PRPO) United States $0.012B 0.00
Strata Skin Sciences (SSKN) United States $0.011B 0.00
Predictive Oncology (POAI) United States $0.010B 0.00
Streamline Health Solutions (STRM) United States $0.010B 0.00
Movano (MOVE) United States $0.007B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Healthcare Triangle (HCTI) United States $0.000B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00